iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!
Reports suggest that patients may experience increased IOP following anti-VEGF therapy. David M. Brown, MD, reviews the data and off…
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!
Reports suggest that patients may experience increased IOP following anti-VEGF therapy. David M. Brown, MD, reviews the data and off…
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!Visit me on Facebook for ad-free browsing through 2011!
In this video commentary, Neil O. Fishman, MD, from SHEA, explains why antimi…
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!Visit me on Facebook for ad-free browsing through 2011!
Ileana PiƱa expresses her concerns about the increase in chronic illness and…
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!Visit me on Facebook for ad-free browsing through 2011!
The wave of reaction to the healthcare reform bill, as Dr. John Marshall sees…
iTunes conversion to RSS provided by Feed Flipper: http://picklemonkey.net/flipper – Click here to donate!
Drs. David Brown, Ingrid Scott, and Peter Campochiaro discuss pivotal data recently presented on the treatment of BRVO and CRVO.
Is neuroprotection a viable treatment option for glaucoma? Drs. Robert Weinreb, Jay Katz, and Theodore Krupin explore the possibilities.
Some drugs that are currently on the market have never been approved by the US Food and Drug Administration (FDA).
Dr. John Marshall asks: If health insurance is a choice that individuals can opt not to have, who pays for the care of the 40 million people in the United States who have no healthcare insurance?
Many people think that privacy of medical treatment should not apply to everyone. An ethics expert tells why privacy protects all of society.
Dr. Margaret Hamburg talks with Dr. Eli Adashi about the complex role of the US Food and Drug Administration in approving new drugs while still ensuring their safety.
John Howard, MD, MPH, JD, Director, NIOSH, talks to Eli Adashi, MD, about the efforts to protect health during and after the Gulf oil spill.
Dr. James Salz discusses the emerging use of lasers to assist in performing cataract surgery.
When physicians make patients feel like it’s "business first, patient care second," they may lose their patients’ respect, says Dr. Gerald Chodak.
As more physicians use EHRs, more ethical issues arise, including patient privacy issues. Also, is it unethical not to use computer technology?
Drs. L. Jay Katz, Ronald Gross, and Brian Francis discuss the evolving medical and surgical approaches to lowering IOP in patients with glaucoma.
If a given diagnosis were covered by 1 lump sum, would physicians recommend less expensive treatments more often? Dr. Gerald Chodak examines the issue.
In this video commentary, Dr. David Brown ponders the new paradigm of pharmacotherapy for diabetic retinopathy — and what this means for laser therapy.
Dr. Jeffrey Lieberman discusses physician vulnerability to legal accusations and offers a simple means of reducing malpractice risk.
Drs. Robert Fechtner and Clark Springs discuss how best to manage 2 challenging cases of patients with co-occurring glaucoma and ocular surface disease.
In this video commentary, Dr. David Brown offers advice regarding time to treatment of the different types of retinal disease entities.